二线抗结核药物的药理学以及与抗逆转录病毒药物相互作用的可能性。 - Suppr

Suppr

超能文献

Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents.

作者信息

Coyne Katherine M, Pozniak Anton L, Lamorde Mohammed, Boffito Marta

出版信息

AIDS. 2009 Feb 20;23(4):437-46. doi: 10.1097/qad.0b013e328326ca50.

DOI:10.1097/qad.0b013e328326ca50

PMID:19256042

Abstract

摘要

相似文献

Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents.二线抗结核药物的药理学以及与抗逆转录病毒药物相互作用的可能性。

AIDS. 2009 Feb 20;23(4):437-46. doi: 10.1097/qad.0b013e328326ca50.

[Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].[人类免疫缺陷病毒/艾滋病患者分枝杆菌感染的诊断与治疗]

Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:20-8.

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.结核病患者抗逆转录病毒治疗的并发症：药物相互作用、毒性及免疫重建炎症综合征。

J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75. doi: 10.1086/518655.

Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者活动性结核病的治疗问题

Clin Infect Dis. 1999 Jan;28(1):130-5. doi: 10.1086/515088.

Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings.

Lancet. 2006 Mar 18;367(9514):944-5. doi: 10.1016/S0140-6736(06)68387-6.

HIV infection-related tuberculosis: clinical manifestations and treatment.HIV 感染相关结核病：临床表现与治疗。

Clin Infect Dis. 2010 May 15;50 Suppl 3:S223-30. doi: 10.1086/651495.

Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.在以结核病为艾滋病定义性疾病的初治 HIV 感染患者中，联合抗逆转录病毒治疗对 CD4 T 细胞计数反应受损。

Clin Infect Dis. 2012 Mar;54(6):853-61. doi: 10.1093/cid/cir900. Epub 2011 Dec 12.

New CDC guidelines call for TB screening and treatment for all HIV-infected individuals.美国疾病控制与预防中心的新指南要求对所有感染艾滋病毒的个体进行结核病筛查和治疗。

J Assoc Nurses AIDS Care. 1999 Mar-Apr;10(2):85-6. doi: 10.1016/s1055-3290(06)60304-x.

Issues in the management of HIV-related tuberculosis.与艾滋病毒相关的结核病管理中的问题

Clin Chest Med. 2005 Jun;26(2):283-94, vi-vii. doi: 10.1016/j.ccm.2005.02.002.

Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?针对结核病患者的高效抗逆转录病毒疗法：是解决方案还是问题所在？

AIDS. 2002 Jul 5;16(10):1436-7. doi: 10.1097/00002030-200207050-00023.

引用本文的文献

Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review.呈现处于不同药物研发阶段的新型抗结核药物的化学类别：2010 - 2020年综述

Pharmaceuticals (Basel). 2021 May 13;14(5):461. doi: 10.3390/ph14050461.

Safety implications of combined antiretroviral and anti-tuberculosis drugs.抗逆转录病毒和抗结核药物联合使用的安全性问题。

Expert Opin Drug Saf. 2020 Jan;19(1):23-41. doi: 10.1080/14740338.2020.1694901. Epub 2019 Dec 6.

Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.特殊亚人群中耐多药结核病的管理，包括合并感染艾滋病毒、妊娠、糖尿病、器官特异性功能障碍以及危重症患者。

J Thorac Dis. 2018 May;10(5):3102-3118. doi: 10.21037/jtd.2018.05.11.

Tuberculosis and pneumonia in HIV-infected children: an overview.感染艾滋病毒儿童的结核病和肺炎：概述

Pneumonia (Nathan). 2016 Nov 24;8:19. doi: 10.1186/s41479-016-0021-y. eCollection 2016.

Getting to 90-90-90 in paediatric HIV: What is needed?实现儿科艾滋病治疗的90-90-90目标：需要什么？

J Int AIDS Soc. 2015 Dec 2;18(7Suppl 6):20770. doi: 10.7448/IAS.18.7.20770. eCollection 2015.

Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.将结核分枝杆菌临床分离株中rrs和eis启动子突变与对二线注射剂的表型药敏水平相关联。

Int J Mycobacteriol. 2016 Mar;5(1):1-6. doi: 10.1016/j.ijmyco.2015.09.001. Epub 2015 Oct 1.

Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children.结核病：HIV感染儿童实现90-90-90目标面临的机遇与挑战

J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20236. doi: 10.7448/IAS.18.7.20236. eCollection 2015.

Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.抗结核药物与抗逆转录病毒药物对细胞色素P450 3A4和P-糖蛋白影响的比较研究

Antimicrob Agents Chemother. 2014 Jun;58(6):3168-76. doi: 10.1128/AAC.02278-13. Epub 2014 Mar 24.

Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.左氧氟沙星前体脂质体：在肺结核治疗中的应用机会。

Pharmaceutics. 2012 Aug 13;4(3):385-412. doi: 10.3390/pharmaceutics4030385.

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.资源有限环境下 HIV 相关结核病的管理：现状综述。

BMC Med. 2013 Dec 2;11:253. doi: 10.1186/1741-7015-11-253.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验